Best in 7 days
Pay in installments of $5.81 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Does GLP 1 Make You Poop? Bowel Effects Explained Fella Health Long Term Effects Of GLP 1 Medications: What You Should Know Introducing Replenza, A GLP 1 Nutritional Support System For People On A GLP 1 Weight Loss Journey Clinical efficacy results from clinical trials comparing different Download Scientific Diagram Common GLP 1 Weight loss Side Effects PillSorted Semaglutide vs. Tirzepatide vs. Retatrutide: Which Weight Loss Treatme NDA Medical Spa
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Discover Niche Categories That Outsell semaglutide columbia sc
Top-Converting Item to Boost Your Average Order
Best in 7 days
Best in 7 days
Best in 7 days
Best in 7 days
4.2 ★★★★★
Based on 1744 reviews
Sort
Product Reviews
★★★★★ 5
Great primer for building LLM Applications
Format: Kindle
I highly recommend the book for anyone who wants to come up to speed on running Ollama for open models. The book is well structure and teach you how to create a working RAG Application. I recommend as a primer for anyone interested in building LLM Applications.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 5, 2025
★★★★★ 5
Breaks down complex concepts into bite-sized, practical chapters.
Format: Kindle
This hands-on guide to Ollama is exactly what I needed! The author breaks down complex concepts into bite-sized, practical chapters that get straight to the point. The sections on different Ollama models and customization were particularly helpful. If you're looking to learn about building local LLM-powered applications without any fluff, this book is a great investment.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 21, 2025
★★★★★ 5
Great helpful book.
Format: Kindle
This book is simple to follow, Greg gets back to you in a very timely manner. I have bought other books from Greg and they are always very helpful.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on February 21, 2025
★★★★★ 5
Love it - revolutionary approach to teaching, presenting complex concepts
Format: Paperback
This book is a game-changer for neural networks and AI enthusiasts. It takes a revolutionary approach to teaching, presenting complex concepts in a simple and engaging manner. The book is filled with colorful diagrams and illustrations that make learning accessible and enjoyable. I’ve read several other books, but this one stands out. It’s not a beginner’s guide, but once you grasp the early concepts, it takes you to a whole new level of understanding. I will give it 10 stars if I could.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on June 18, 2025
★★★★★ 5
Great book to understand Neural Networks!
Format: Paperback
Loved the book and I highly recommend. It was thorough and very easy to understand.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on December 1, 2025
recommand products
Best Time to Take Tirzepatide
20.13
Tirzepatide Morning or Night: Best Time to Take Your Injection
29.35
Welcome news for our patients paying out of pocket for #tirzepatide ' #zepbound with the introduction of the multi-dose pens. #weightloss #health
28.48
How Long Does Tirzepatide Stay in Your System?
22.48
The Outsourcing Facilities Association (OFA) is suing the FDA after the agency removed tirzepatide (Zepbound, Mounjaro) from the federal drug shortage list without proper notice. The lawsuit claims that the FDA failed
23.65